Procalcitonin guided antibiotic therapy in patients presenting with fever in the emergency department

Journal of Infection

Volumn 69, Issue 4, 2014, Pages 410-412

  Limper, M ^a   van der Does, Y ^a   Brandjes, D P M ^b,c   De Kruif, M D ^c   Rood, P P M ^a   van Gorp, E C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN; CALCITONIN; PROTEIN PRECURSOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIUM CULTURE; BLOODSTREAM INFECTION; BODY TEMPERATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EMERGENCY WARD; FEVER; GASTROINTESTINAL INFECTION; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LETTER; MAJOR CLINICAL STUDY; MENINGOENCEPHALITIS; NEUROLEPTIC MALIGNANT SYNDROME; POLYMERASE CHAIN REACTION; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RHEUMATIC POLYMYALGIA; SKIN INFECTION; SOFT TISSUE INFECTION; THYROTOXICOSIS; TREND STUDY; URINARY TRACT INFECTION; VIRUS CULTURE; BLOOD; FEMALE; MALE;

BACTEREMIA; BIOLOGICAL MARKERS; CALCITONIN; FEMALE; HUMANS; MALE; PROTEIN PRECURSORS;

EID: 84908500973     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.04.009     Document Type: Letter

References (9)

1. Tromp M., Lansdorp B., Bleeker-Rovers C.P., Gunnewiek J.M., Kullberg B.J., Pickkers P. Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. J Infect 2012, 65(4):292-301.
2. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39(2):165-228.
3. Hitti E.A., Lewin J.J., Lopez J., Hansen J., Pipkin M., Itani T., et al. Improving door-to-antibiotic time in severely septic emergency department patients. J Emerg Med 2012, 42(4):462-469.
4. Lesprit P., Brun-Buisson C. Hospital antibiotic stewardship. Curr Opin Infect Dis 2008, 21(4):344-349.
5. Bouadma L., Luyt C.E., Tubach F., Cracco C., Alvarez A., Schwebel C., et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375(9713):463-474.
6. Schuetz P., Chiappa V., Briel M., Greenwald J.L. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011, 171(15):1322-1331.
7. Albrich W.C., Dusemund F., Bucher B., Meyer S., Thomann R., Kuhn F., et al. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL). Arch Intern Med 2012, 172(9):715-722.
8. Schuetz P., Christ-Crain M., Thomann R., Falconnier C., Wolbers M., Widmer I., et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009, 302(10):1059-1066.
9. Gilbert D. Serum procalcitonin levels: comment on "Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in 'real life'". Arch Intern Med 2012, 172(9):722-723.